The trajectory of companies tied to blockbuster drugs like Viagra presents a complex investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key markets has introduced considerable uncertainty . Investors are now facing the consequences of lower-cost alterna